MetaCap

Direxion Daily S&P Biotech Bear 3X ETF (LABD)

NYSEARCA: LABDDirexion FundsTrading--Inverse EquityETFUSD

9.11+0.70 (+8.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LABD chart

Full chart

Key facts

Holdings
—
Inception
May 28, 2015
Issuer
Direxion Funds
Index tracked
—
Category
Trading--Inverse Equity
52-week range
5.81 – 24.82
Volume / Avg
19.34M / 23.69M
Beta
—
Previous close
8.41

LABD ETF today

The Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund from Direxion Funds in the Trading--Inverse Equity category. It charges an expense ratio of 1.07%, or $107.00 per year on a $10,000 investment, and manages $80.7 million in assets. LABD is down 56.7% year to date and has lost 63.6% over the past 12 months; over five years its price has changed -96.4%.

The fund's trailing dividend yield is 6.59%. LABD launched on May 28, 2015.

Summary generated from market data by MetaCap's automated system. Methodology

LABD performance

1 week

+22.78%

1 month

+22.12%

3 months

+44.83%

6 months

-36.34%

Year to date

-56.74%

1 year

-63.62%

3 years

-95.02%

5 years

-96.38%

LABD price return, excluding dividends.

ETFs similar to LABD

LABD ETF FAQ

What is the LABD price today?

LABD last traded at $9.11 as of Nov 20, 4:00 PM EST, up 8.32% on the day.

What is LABD's expense ratio?

LABD has an expense ratio of 1.07%, which works out to about $107.00 per year for every $10,000 invested.

Does LABD pay a dividend?

Yes. LABD has a trailing dividend yield of 6.59% and pays quarterly distributions; the most recent was $0.071 per share with an ex-dividend date of Sep 22, 2026.

How big is LABD?

LABD has about $80.7 million in assets under management.

Explore